Shire Signals Support For Landmark $53B AbbVie Merger
AbbVie Inc.'s contentious chase for British drugmaker Shire PLC neared its end on Monday when the target said it would likely bow to a sweetened £30.1 billion ($53 billion) bid, paving...To view the full article, register now.
Already a subscriber? Click here to view full article